These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32424980)

  • 21. Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT.
    Peters AE; Pandey A; Ayers C; Wegermann K; McGarrah RW; Grodin JL; Abdelmalek MF; Bekfani T; Blumer V; Diehl AM; Moylan CA; Fudim M
    ESC Heart Fail; 2021 Apr; 8(2):842-848. PubMed ID: 33586354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Body-Weight Fluctuation With Outcomes in Heart Failure With Preserved Ejection Fraction.
    Li Y; Yu Y; Wu Y; Liang W; Dong B; Xue R; Dong Y; Zhu W; Huang P
    Front Cardiovasc Med; 2021; 8():689591. PubMed ID: 34195237
    [No Abstract]   [Full Text] [Related]  

  • 23. Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction.
    Sandesara PB; Hammadah M; Samman-Tahhan A; Kelli HM; O'Neal WT
    Clin Cardiol; 2017 Sep; 40(9):692-696. PubMed ID: 28444995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis.
    Segar MW; Patel KV; Ayers C; Basit M; Tang WHW; Willett D; Berry J; Grodin JL; Pandey A
    Eur J Heart Fail; 2020 Jan; 22(1):148-158. PubMed ID: 31637815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Essen Stroke Risk Score Predicts Clinical Outcomes in Heart Failure Patients with Preserved Ejection Fraction: Evidence from the TOPCAT trial.
    Zhu W; Cao Y; Ye M; Huang H; Wu Y; Ma J; Dong Y; Liu X; Liu C; Lip GYH
    Thromb Haemost; 2023 Jan; 123(1):85-96. PubMed ID: 36037830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
    Shen L; Jhund PS; Docherty KF; Petrie MC; Anand IS; Carson PE; Desai AS; Granger CB; Komajda M; McKelvie RS; Pfeffer MA; Solomon SD; Swedberg K; Zile MR; McMurray JJV
    JACC Heart Fail; 2019 May; 7(5):418-427. PubMed ID: 30981744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation in clinical and patient-reported outcomes among complex heart failure with preserved ejection fraction phenotypes.
    Flint KM; Shah SJ; Lewis EF; Kao DP
    ESC Heart Fail; 2020 Jun; 7(3):811-824. PubMed ID: 32160420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perturbations in serum chloride homeostasis in heart failure with preserved ejection fraction: insights from TOPCAT.
    Grodin JL; Testani JM; Pandey A; Sambandam K; Drazner MH; Fang JC; Tang WHW
    Eur J Heart Fail; 2018 Oct; 20(10):1436-1443. PubMed ID: 29893446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QRS Duration Is a Predictor of Adverse Outcomes in Heart Failure With Preserved Ejection Fraction.
    Joseph J; Claggett BC; Anand IS; Fleg JL; Huynh T; Desai AS; Solomon SD; O'Meara E; Mckinlay S; Pitt B; Pfeffer MA; Lewis EF
    JACC Heart Fail; 2016 Jun; 4(6):477-86. PubMed ID: 27039126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart failure with preserved ejection fraction: comparison of patients with and without angina pectoris (from the Duke Databank for Cardiovascular Disease).
    Mentz RJ; Broderick S; Shaw LK; Fiuzat M; O'Connor CM
    J Am Coll Cardiol; 2014 Jan; 63(3):251-8. PubMed ID: 24161322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction.
    Segar MW; Patel RB; Patel KV; Fudim M; DeVore AD; Martens P; Hedayati SS; Grodin JL; Tang WHW; Pandey A
    JAMA Cardiol; 2021 Jan; 6(1):68-77. PubMed ID: 33206129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection Fraction.
    Myhre PL; O'Meara E; Claggett BL; de Denus S; Jarolim P; Anand IS; Beldhuis IE; Fleg JL; Lewis E; Pitt B; Rouleau JL; Solomon SD; Pfeffer MA; Desai AS
    Circ Heart Fail; 2018 Nov; 11(11):e005312. PubMed ID: 30571192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Hyper-Polypharmacy With Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Minamisawa M; Claggett B; Suzuki K; Hegde SM; Shah AM; Desai AS; Lewis EF; Shah SJ; Sweitzer NK; Fang JC; Anand IS; O'Meara E; Rouleau JL; Pitt B; Pfeffer MA; Solomon SD; Vardeny O
    Circ Heart Fail; 2021 Nov; 14(11):e008293. PubMed ID: 34674539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent heart failure hospitalizations in heart failure with preserved ejection fraction: an analysis of TOPCAT trial.
    Wang Q; Yu F; Su H; Liu Z; Hu K; Wu G; Yan J; Chen K; Yang D
    ESC Heart Fail; 2024 Feb; 11(1):475-482. PubMed ID: 38054211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diuretic and renal effects of spironolactone and heart failure hospitalizations: a TOPCAT Americas analysis.
    Kalogeropoulos AP; Thankachen J; Butler J; Fang JC
    Eur J Heart Fail; 2020 Sep; 22(9):1600-1610. PubMed ID: 32469156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Malnutrition Using Geriatric Nutritional Risk Index in Heart Failure With Preserved Ejection Fraction.
    Minamisawa M; Seidelmann SB; Claggett B; Hegde SM; Shah AM; Desai AS; Lewis EF; Shah SJ; Sweitzer NK; Fang JC; Anand IS; O'Meara E; Rouleau JL; Pitt B; Solomon SD
    JACC Heart Fail; 2019 Aug; 7(8):664-675. PubMed ID: 31302049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease.
    Beldhuis IE; Myhre PL; Claggett B; Damman K; Fang JC; Lewis EF; O'Meara E; Pitt B; Shah SJ; Voors AA; Pfeffer MA; Solomon SD; Desai AS
    JACC Heart Fail; 2019 Jan; 7(1):25-32. PubMed ID: 30606484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
    Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
    ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Living Alone and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
    Zhu W; Wu Y; Zhou Y; Liang W; Xue R; Wu Z; Wu D; He J; Dong Y; Liu C
    Psychosom Med; 2021 Jun; 83(5):470-476. PubMed ID: 33901053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic impact of abnormal sodium burden in heart failure patients with preserved ejection fraction.
    Zhen Z; Choy M; Dong B; Dong Y; Liang W; Liu C; Xue R
    Eur J Clin Invest; 2024 Feb; 54(2):e14115. PubMed ID: 37877605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.